|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-4-5
|
|
pubmed:abstractText |
Recent ventilator-associated pneumonia (VAP) guidelines recommend considering abbreviated therapy in patients with non-Pseudomonas aeruginosa VAP if clinical signs resolve. However, using an arbitrary day cutoff or clinical signs can be suboptimal for some, especially multiply injured patients, resulting in relapse and/or antibiotic resistance. Previously, we showed that repeat bronchoalveolar lavage (BAL) could guide antimicrobial duration for community-acquired VAP in trauma patients. The purpose of this study was to determine the appropriate duration of antimicrobial therapy for VAP in trauma patients secondary to hospital-acquired pathogens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1879-1190
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 American College of Surgeons. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
212
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
476-84; discussion 484-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21463773-Acinetobacter baumannii,
pubmed-meshheading:21463773-Adolescent,
pubmed-meshheading:21463773-Adult,
pubmed-meshheading:21463773-Aged,
pubmed-meshheading:21463773-Aged, 80 and over,
pubmed-meshheading:21463773-Anti-Infective Agents,
pubmed-meshheading:21463773-Bronchoalveolar Lavage,
pubmed-meshheading:21463773-Cohort Studies,
pubmed-meshheading:21463773-Drug Administration Schedule,
pubmed-meshheading:21463773-Enterobacteriaceae,
pubmed-meshheading:21463773-Female,
pubmed-meshheading:21463773-Gram-Negative Bacterial Infections,
pubmed-meshheading:21463773-Gram-Positive Bacterial Infections,
pubmed-meshheading:21463773-Humans,
pubmed-meshheading:21463773-Length of Stay,
pubmed-meshheading:21463773-Male,
pubmed-meshheading:21463773-Methicillin-Resistant Staphylococcus aureus,
pubmed-meshheading:21463773-Middle Aged,
pubmed-meshheading:21463773-Pneumonia, Ventilator-Associated,
pubmed-meshheading:21463773-Pseudomonas aeruginosa,
pubmed-meshheading:21463773-Retrospective Studies,
pubmed-meshheading:21463773-Stenotrophomonas maltophilia,
pubmed-meshheading:21463773-Treatment Outcome,
pubmed-meshheading:21463773-Wounds and Injuries,
pubmed-meshheading:21463773-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
|
|
pubmed:affiliation |
Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38163, USA. lmagnott@utmem.edu
|
|
pubmed:publicationType |
Journal Article
|
